Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorlí L, et al. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect. 2016;22:732.e1-732.e8.

Article  CAS  PubMed  Google Scholar 

Zimmerli W. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.

Article  CAS  PubMed  Google Scholar 

Rodríguez-Pardo D, Pigrau C, Lora-Tamayo J, Soriano A, Del Toro MD, Cobo J, et al. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach: a large multicentre study. Clin Microbiol Infect. 2014;20:O911–9.

Article  PubMed  Google Scholar 

Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.

Article  CAS  PubMed  Google Scholar 

Zimmerli W. Bone and joint infections: from microbiology to diagnostics and treatment. 2nd ed. Hoboken, NJ, USA: Wiley-Blackwell; 2021.

Book  Google Scholar 

Hengzhuang W, Ciofu O, Yang L, Wu H, Song Z, Oliver A, et al. High β-lactamase levels change the pharmacodynamics of β-Lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2013;57:196–204.

Article  PubMed  PubMed Central  Google Scholar 

McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. 2008;31:345–51.

Article  CAS  PubMed  Google Scholar 

Mouton JW, Den Hollander JG. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. 1994;38:931–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herrmann G, Yang L, Wu H, Song Z, Wang H, Høiby N, et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis. 2010;202:1585–92.

Article  CAS  PubMed  Google Scholar 

Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol. 2008;68:223–40.

Article  CAS  PubMed  Google Scholar 

Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo X, et al. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. J Antimicrob Chemother. 2014;69:2434–42.

Article  CAS  PubMed  Google Scholar 

Crémieux A-C, Dinh A, Nordmann P, Mouton W, Tattevin P, Ghout I, et al. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2019;74:2666–75.

Article  PubMed  Google Scholar 

Ribera A, Benavent E, Lora-Tamayo J, Tubau F, Pedrero S, Cabo X, et al. Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams. J Antimicrob Chemother. 2015;70:3357–65.

CAS  PubMed  Google Scholar 

Gómez-Junyent J, Rigo-Bonnin R, Benavent E, Soldevila L, Padullés A, Cabo X, et al. Efficacy and therapeutic drug monitoring of continuous beta-lactam infusion for osteoarticular infections caused by fluoroquinolone-resistant Pseudomonas aeruginosa: a prospective cohort study. Eur J Drug Metab Pharmacokinet. 2020;45:587–99.

Article  PubMed  Google Scholar 

Sorlí L, Luque S, Grau S, Berenguer N, Segura C, Montero MM, et al. Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis. 2013;13:380.

Article  PubMed  PubMed Central  Google Scholar 

Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1-25.

Article  PubMed  Google Scholar 

Metsemakers WJ, Kuehl R, Moriarty TF, Richards RG, Verhofstad MHJ, Borens O, et al. Infection after fracture fixation: current surgical and microbiological concepts. Injury. 2018;49:511–22.

Article  CAS  PubMed  Google Scholar 

Ariza J, Cobo J, Baraia-Etxaburu J, Benito N, Bori G, Cabo J, et al. Executive summary of management of prosthetic joint infections: clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enferm Infecc Microbiol Clín. 2017;35:189–95.

Article  PubMed  Google Scholar 

Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mouton JW, Vinks AA. Continuous infusion of beta-lactams. Curr Opin Crit Care. 2007;13:598–606.

Article  PubMed  Google Scholar 

Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1.

Article  CAS  PubMed  Google Scholar 

Moriyama B, Henning SA, Childs R, Holland SM, Anderson VL, Morris JC, et al. High-dose continuous infusion β-lactam antibiotics for the treatment of resistant Pseudomonas Aeruginosa infections in immunocompromised patients. Ann Pharmacother. 2010;44:929–35.

Article  PubMed  PubMed Central  Google Scholar 

Guilhaumou R, Benaboud S, Bennis Y, Dahyot-Fizelier C, Dailly E, Gandia P, et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR). Crit Care. 2019;23:104.

Article  PubMed  PubMed Central  Google Scholar 

Ribera A, Soldevila L, Rigo-Bonnin R, Tubau F, Padullés A, Gómez-Junyent J, et al. Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use. Infection. 2018;46:239–44.

Article  CAS  PubMed  Google Scholar 

Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Johnson DW. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci App. 2001;761:167–75.

Article  CAS  Google Scholar 

Rigo-Bonnin R, Ribera A, Arbiol-Roca A, Cobo-Sacristán S, Padullés A, Murillo Ò, et al. Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma. Clin Chim Acta. 2017;468:215–24.

Article  CAS  PubMed  Google Scholar 

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, 2020. [Internet]. Available from: http://www.eucast.org.

Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, et al. Difficult-to-treat resistance in Gram-negative Bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018. https://doi.org/10.1093/cid/ciy378/5057528.

Article  PubMed  PubMed Central  Google Scholar 

Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

Article  PubMed  PubMed Central  Google Scholar 

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

Article  CAS  PubMed  Google Scholar 

Martínez-Pastor JC, Muñoz-Mahamud E, Vilchez F, García-Ramiro S, Bori G, Sierra J, et al. Outcome of acute prosthetic joint infections due to gram-negative Bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agent